Jéssica Lopes de Oliveira

Ms. Jéssica Lopes de Oliveira

Biotechnology, Universidade Nove de Julho, São Paulo, Brazil
orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 March 2024 in Toxins
Verified
Journal Article
Open access
PDF file
Henrique Roman-RamosHenrique Roman-Ramos
Henrique Roman-Ramos
ASAlvaro R. B. Prieto da Silva
Alvaro R. B. Prieto da Silva
HDHumberto Delle
Humberto Delle
RFRafael S. Floriano
Rafael S. Floriano
LDLourdes Dias
Lourdes Dias
Paulo Lee HoPaulo Lee Ho
Paulo Lee Ho
Coralsnakes (Micrurus spp.) are the only elapids found throughout the Americas. They are recognized for their highly neurotoxic venom, which is comprised of a wide variety of toxins, including the stable, low-mass toxins known as three-finger toxins (3FTx). Due to difficulties in venom extraction and availability, research on coralsnake venoms is still very limited when compared to that of other Elapidae snakes like cobras, kraits, and mambas. In this study, two previously described 3FTx from the venom of M. corallinus, NXH1 (3SOC1_MICCO), and NXH8 (3NO48_MICCO) were characterized. Using in silico, in vitro, and ex vivo experiments, the biological activities of these toxins were predicted and evaluated. The results showed that only NXH8 was capable of binding to skeletal muscle cells and modulating the activity of nAChRs in nerve–diaphragm preparations. These effects were antagonized by anti-rNXH8 or antielapidic sera. Sequence analysis revealed that the NXH1 toxin possesses eight cysteine residues and four disulfide bonds, while the NXH8 toxin has a primary structure similar to that of non-conventional 3FTx, with an additional disulfide bond on the first loop. These findings add more information related to the structural diversity present within the 3FTx class, while expanding our understanding of the mechanisms of the toxicity of this coralsnake venom and opening new perspectives for developing more effective therapeutic interventions.

14 February 2026 in Receptors
Verified
Journal Article
Open access
PDF file
Jéssica Lopes de OliveiraJéssica Lopes de Oliveira
Jéssica Lopes de Oliveira
Henrique Roman-RamosHenrique Roman-Ramos
Henrique Roman-Ramos
Background: Three-finger toxins (3FTxs) are a major axis of functional diversification in advanced snake venoms, with canonical paralytic activity mediated through muscle-type nicotinic acetylcholine receptors (nAChRs) and a broader set of non-nicotinic targets. This review integrates evidence bearing on coevolution between 3FTxs and target receptors, spanning toxin origin, diversification, receptor evolution, and ecological context. Methods: The synthesis draws on comparative genomic and transcriptomic studies of 3FTx gene-family evolution, codon-model analyses of selection, structural characterisation of toxin–receptor interfaces, and functional assays (including receptor-mimicking peptide binding) that link sequence variation to binding and toxicity. Results: Across lineages, 3FTx diversification is repeatedly structured by strong constraint on the disulphide-rich scaffold with accelerated change concentrated in solvent-exposed loops, alongside birth–death dynamics and exon/segment-level innovation that expand binding specificity. On the receptor side, resistance-associated variation is most intensively characterised for the nAChR α1 orthosteric site and includes convergent, mechanistically distinct solutions such as electrostatic repulsion and glycosylation-mediated steric interference. Within the predominantly elapid systems currently examined, integrative datasets indicate that prey-selective binding and geographically variable susceptibility can arise from modest substitutions at toxin–receptor interfaces, but they also reveal substantial taxonomic and target-specific biases. Conclusions: Current evidence supports adaptive diversification in both toxins and receptors, while broader evolutionary interpretations are limited by uneven sampling and the frequent lack of matched toxin and receptor variants analysed within a common evolutionary framework. Development of predictive models will require joint pipelines linking genomics, structure-informed evolutionary inference, scalable functional assays, and explicit ecological network context.

7 May 2026 in International Journal of Urology
Verified
Journal Article
Open access
DLDouglas Edgard Lemes
Douglas Edgard Lemes
ASAline Áurea de Souza Santos
Aline Áurea de Souza Santos
Jéssica Lopes de OliveiraJéssica Lopes de Oliveira
Jéssica Lopes de Oliveira
Henrique Roman-RamosHenrique Roman-Ramos
Henrique Roman-Ramos
AMAna Carolina Ramos Moreno
Ana Carolina Ramos Moreno
HDHumberto Dellê
Humberto Dellê
L‐tryptophan (Trp) metabolism through the L‐kynurenine (Kyn) pathway contributes to immune escape in neoplasms, including bladder cancer (BC). Indoleamine 2,3‐dioxygenase‐1 (IDO1) is a key enzyme, and its catabolites—Kyn, 3‐hydroxykynurenine (3HK), and 3‐hydroxyanthranilate (3HAA)—depend on other enzymes and play a crucial role in immunomodulation. Objectives: We investigated the association between Kyn pathway enzyme expression and BC prognostic factors. Methods: Data from 165 bc patients in the GEO DataSets were analyzed, comparing staging, tumor grade, progression, and recurrence with the expression of IDO1, arylformamidase (AFMID), kynurenine–oxoglutarate transaminase (KAT), kynureninase (KYNU), kynurenine 3‐monooxygenase (KMO), 3‐hydroxyanthranilate 3,4‐dioxygenase (HAAO), and aminocarboxymuconate‐semialdehyde decarboxylase (ACMSD). Predictive genes were further evaluated in RT4 (low‐grade, non‐invasive) and T24 (high‐grade, invasive) BC cells treated with IFN‐gamma and the IDO1 inhibitor INCB024360. Trp catabolites were quantified in the supernatant. Results: Enzyme expression varied widely, especially for IDO1, AFMID, KAT, KMO, and KYNU. IDO1 correlated positively with KMO and negatively with KAT. High IDO1 and KMO levels were linked to advanced‐stage disease, while KAT and KYNU were associated with earlier stages and lower tumor grade. RT4 and T24 cells showed distinct basal enzyme expression, with T24 cells being more responsive to IFN‐gamma, increasing IDO1 and KYNU while decreasing KAT and KMO. These effects were inhibited by INCB024360. High Trp consumption increased Kyn and 3HAA but not 3HK. Conclusions: Kyn pathway enzyme expression varies with disease progression and may indicate immune activity by influencing tumor microenvironment catabolites. BC cell sensitivity to immune stimuli differs, potentially shaping distinct immune escape mechanisms.